Staphylococcal bacteraemia with a fulminant course. Comparative study in vitro and in vivo.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004917:Erythromycin / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D007612:Kanamycin / Q000627:therapeutic use; D008034:Lincomycin / Q000627:therapeutic use; D051379:Mice; D008826:Microbial Sensitivity Tests; D011817:Rabbits; D018805:Sepsis / Q000188:drug therapy / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013210:Staphylococcus / Q000187:drug effects*; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D007612:Kanamycin; D004917:Erythromycin; D008034:Lincomycin; D013752:Tetracycline